• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲硝唑栓在兔体内的体外评价及阴道吸收情况

In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.

作者信息

Ozyazici Mine, Turgut Evren H, Taner Memduh S, Köseoglu Kamil, Ertan Gökhan

机构信息

Faculty of Pharmacy, Department of Pharmaceutical Technology, University of Ege, Bornova, Izmir, Turkey.

出版信息

J Drug Target. 2003 Apr;11(3):177-85. doi: 10.1080/10611860310001603814.

DOI:10.1080/10611860310001603814
PMID:14577974
Abstract

Vaginal suppository formulations of metronidazole were prepared using six different bases as Witepsol H15, Cremao, Ovucire WL2944, Ovucire WL3264, PEG 1500, PEG 6000. Three different dissolution methods were used to evaluate the in vitro drug release from the suppositories. The diffusion studies were performed through synthetic (cellophane) and natural membrane (rabbit vagina), but the drug did not show good permeation characteristics from natural membrane. Ovucire WL3264 suppositories of metronidazole labeled with 99mTc (Tecnetium-99m) were used for the vaginal absorption and biodistribution studies in the rabbits. Scintigraphic images were collected after vaginal administration of the labeled suppositories using SPECT gamma fitted with a low energy, high-resolution parallel hole collimator. The labeled drug showed high biodistribution in urine beside vaginal site. The results of this study suggested that the Ovucire WL3264 suppository of metronidazole prepared for vaginal infections could also be effective in the urinary infections.

摘要

采用六种不同基质(如Witepsol H15、Cremao、Ovucire WL2944、Ovucire WL3264、聚乙二醇1500、聚乙二醇6000)制备了甲硝唑阴道栓剂。使用三种不同的溶出方法来评估栓剂的体外药物释放。通过合成膜(玻璃纸)和天然膜(兔阴道)进行扩散研究,但药物在天然膜上未表现出良好的渗透特性。用99m锝(锝-99m)标记的甲硝唑Ovucire WL3264栓剂用于兔的阴道吸收和生物分布研究。使用配备低能、高分辨率平行孔准直器的单光子发射计算机断层扫描(SPECT)γ相机在阴道给药标记栓剂后采集闪烁图像。标记药物除在阴道部位外,在尿液中也显示出较高的生物分布。本研究结果表明,为治疗阴道感染而制备的甲硝唑Ovucire WL3264栓剂对泌尿系统感染也可能有效。

相似文献

1
In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.甲硝唑栓在兔体内的体外评价及阴道吸收情况
J Drug Target. 2003 Apr;11(3):177-85. doi: 10.1080/10611860310001603814.
2
Dissolution and vaginal absorption characteristics of metronidazole and ornidazole.
Pharmazie. 2006 Oct;61(10):855-61.
3
Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.含嗜酸乳杆菌的阴道栓剂:研发与特性研究
Drug Dev Ind Pharm. 2015;41(9):1518-25. doi: 10.3109/03639045.2014.963864. Epub 2015 Jul 14.
4
Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.药物溶解度对含聚乙二醇辅料栓剂体外释放率的影响。
Pharmazie. 2001 Feb;56(2):163-7.
5
Release and rectal absorption of aminophylline suppositories prepared in a hospital pharmacy.
Tokai J Exp Clin Med. 1982 Sep;7(5):539-46.
6
The release of isoconazole nitrate from different suppository bases: in-vivo release of drug labelled with 99mTc in rabbits.硝酸异康唑从不同栓剂基质中的释放:家兔体内99mTc标记药物的释放情况
J Pharm Pharmacol. 1995 Sep;47(9):717-20. doi: 10.1111/j.2042-7158.1995.tb06729.x.
7
The release of isoconazole nitrate from different suppository bases: in-vitro dissolution, physicochemical and microbiological studies.硝酸异康唑从不同栓剂基质中的释放:体外溶出度、理化性质及微生物学研究。
J Pharm Pharmacol. 1995 Sep;47(9):713-6. doi: 10.1111/j.2042-7158.1995.tb06728.x.
8
[The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
Pharmazie. 1981;36(1):20.
9
Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).栓剂基质对一种强效抗菌剂(C31G)释放特性的影响。
Pharmazie. 1994 May;49(5):336-9.
10
Release and rectal absorption of ethosuximide from suppositories in rabbits.乙琥胺在兔体内从栓剂中的释放及直肠吸收
Pharmazie. 1988 Jul;43(7):484-5.